The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
- Autores
- Mattera, Vanesa Soledad
- Año de publicación
- 2025
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.
Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina - Materia
-
OLIGODENDROCYTES
MYELINATION
EXTRACELLULAR VESICLES
IRON - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/282503
Ver los metadatos del registro completo
| id |
CONICETDig_c2fbefe3987f4a202f5e756302548a00 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/282503 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances RemyelinationMattera, Vanesa SoledadOLIGODENDROCYTESMYELINATIONEXTRACELLULAR VESICLESIRONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; ArgentinaWiley Blackwell Publishing, Inc2025-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/282503Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-60022-3042CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/jnc.70260info:eu-repo/semantics/altIdentifier/doi/10.1111/jnc.70260info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-03-11T12:55:11Zoai:ri.conicet.gov.ar:11336/282503instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-03-11 12:55:12.106CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| title |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| spellingShingle |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination Mattera, Vanesa Soledad OLIGODENDROCYTES MYELINATION EXTRACELLULAR VESICLES IRON |
| title_short |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| title_full |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| title_fullStr |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| title_full_unstemmed |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| title_sort |
The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination |
| dc.creator.none.fl_str_mv |
Mattera, Vanesa Soledad |
| author |
Mattera, Vanesa Soledad |
| author_facet |
Mattera, Vanesa Soledad |
| author_role |
author |
| dc.subject.none.fl_str_mv |
OLIGODENDROCYTES MYELINATION EXTRACELLULAR VESICLES IRON |
| topic |
OLIGODENDROCYTES MYELINATION EXTRACELLULAR VESICLES IRON |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization. Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina |
| description |
Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-10 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/282503 Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-6 0022-3042 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/282503 |
| identifier_str_mv |
Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-6 0022-3042 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/jnc.70260 info:eu-repo/semantics/altIdentifier/doi/10.1111/jnc.70260 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
| publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1859460888505876480 |
| score |
12.977003 |